Skip to main content
Home

Call Us: 1-800-339-6484

    • Home
      • About Us
        • Mission & Values
        • NHOH In The News
        • Feedback
        • Career Opportunities
      • Our Team
        • Advance Practice Providers
        • Physicians
      • Locations & Directions
    • Office info
      • Your 1st Visit
      • Navigating Through The Office
      • Insurance Information
      • Affording Your Care
      • Refilling Your Prescription
      • HIPAA Notice
      • Referral Policy
      • Emergency Closing Information
      • Nondiscrimination Notice
    • Newly Diagnosed
      • What is Cancer?
      • Diagnosing Cancer
      • Intro to Cancer Treatments
      • Questions to Ask
      • A Word About Clinical Trials
      • The Role Of Caregivers
      • Types Of Cancer
      • Testing
    • Treatments
      • Chemotherapy
      • Radiation Therapy
      • Surgery
      • Hormonal Therapy
      • Targeted Therapy
      • Complementary & Alternative
      • Managing Side Effects
      • Support And Resources
    • Clinical Trials
      • Research Spotlight
      • What Are Clinical Trials?
      • Phases Of Clinical Trials
      • Participating In Clinical Trials
      • The Cost Of Clinical Trials
      • Open Clinical Trials
    • Hematology
      • What is Hematology?
      • Types Of Blood Diseases
      • Hematology Links
    • News

Cancer News

  • NCI study outlines opportunities to achieve President Biden’s Cancer Moonshot goal of reducing cancer death rates in the United States Mon, Apr 17 2023
    A new study has outlined opportunities for achieving President Biden and First Lady Biden’s Cancer Moonshot goal of reducing the cancer death rate by at least 50% over the next 25 years.
  • Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients Wed, Apr 12 2023
    NCI has helped launch the Pragmatica-Lung Study, a phase 3 randomized clinical trial of a two-drug combination to treat patients with advanced non-small cell lung cancer. The simplified trial design aims to increase accessibility for participants.
  • NCI study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis Tue, Apr 04 2023
    An NCI study shows that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.
  • Cancer Grand Challenges announces global research funding opportunity with nine new challenges Wed, Mar 08 2023
    As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
    • Home
    • Newly Diagnosed
    • Your 1st Visit
    • Navigating NHOH
    • Insurance Information
    • Affording Your Care
    • Prescriptions
    • HIPAA Notice
    • Referral Policy
    • About Us
    • Our Team
    • Directions
    • Career Opportunities
    • Patient Bill Of Rights

Follow Us

Copyright © 2015- All Rights Reserved. Designed & Hosted by RightPath Media